EIDB Presentations at CROI 2024

LTC Natalie Collins, Director of EIDB at WRAIR, and Dr. Gordon Joyce are presenting at the 31st Conference on Retroviruses and Opportunistic Infections (CROI). 

LTC Natalie Collins

  • Title: (02827) First-in-Human Phase I Trial of an Adjuvanted SARS-CoV-2 Spike Ferritin Nanoparticle Vaccine
  • Date/Time: March 5, 2:30 - 4:30 PM MST
  • Session: Treatment and Prevention of SARS-CoV-2 Infection - Poster Session-G6

Gordon Joyce

  • Title: (01331) Sarbecovirus Ferritin Nanoparticle Vaccines as Protein or mRNA-LNP Elicit Broad Immunogenicity"
  • Date/Time: March 4, 2:30 - 4:30 PM MST
  • Session: COVID-19 Vaccines -Poster Session-C3